Article By:
Tarun Chandra, CFA
Tuesday, January 1, 2019 1:04 PM EDT
In 2019 biotech stocks will have an uphill battle, but will still provide opportunities for attractive gains.
In this article: IBB, SPY, XBI, XLV, MRNA, TSRO Also: AGN, BMY, JNJ, MRK, NVS, PFE, AMGN, LLY, AZN, GSK, ALXN, REGN, CVS, ESRX, VRTX
Alert: Alzheimer’s Drug Fails In Clinical Trial - Stocks Sink
What are the chances of $BIIB and $TSRO being bought out? They have long been targets, or at least rumored to be, for consolidation.